By Abdul Rahman Jazieh MD, MPH – Director of Innovation & Research at Naples Cancer Advisors
March is Colorectal Cancer Awareness Month, a crucial time to shed light on a disease that remains a leading cause of cancer-related deaths in the United States. One of the most alarming trends in colorectal cancer is the rising incidence among younger adults. While this disease has historically been associated with individuals over 50, recent studies show a significant increase in cases among people in their 30s and 40s. The exact cause remains under investigation, but researchers are examining factors such as diet, lifestyle, gut microbiome changes, and genetic predispositions. This trend underscores the urgent need for awareness and, in some cases, earlier screening.
Colorectal Cancer in Southwest Florida
In Florida, colorectal cancer is one of the most commonly diagnosed cancers and a leading cause of cancer-related deaths. According to the Florida Cancer Data System, thousands of new cases are reported each year, making screening and early detection critical for saving lives.
Screening: The Key to Prevention
Dr. Abdul Jazieh, the lead physician for colorectal and gastrointestinal cancers at Naples Cancer Advisors, emphasizes that screening is the most effective tool for reducing colorectal cancer incidence and mortality. The American Cancer Society recommends that individuals at average risk begin screening at age 45, but those with family history or genetic risk factors may need to start even earlier.
There are multiple screening options available, each with its own advantages:
• Colonoscopy – The gold standard for detecting colorectal cancer, this procedure allows doctors to examine the colon and remove precancerous polyps. A normal colonoscopy means you may not need another for 10 years.
• Stool-Based Tests (e.g., Cologuard, FIT Test) – These detect hidden blood or abnormal DNA markers in stool samples. They are less invasive but must be repeated more frequently. A positive test result requires a follow-up colonoscopy.
Colonoscopy vs. Cologuard: Which is Right for You?
While colonoscopy remains the most comprehensive screening method, some individuals prefer stool-based tests due to convenience and non-invasiveness. Cologuard is a good option for those at average risk who are hesitant about a colonoscopy. However, it is not recommended for high-risk individuals, those with symptoms, or those with a family history of colorectal cancer. Dr. Jazieh advises patients to discuss screening choices with their physician to ensure the best approach for their specific needs.
Advances in Treatment
Thanks to medical advancements, colorectal cancer treatment has evolved significantly, improving survival rates and patient outcomes.
• Minimally Invasive Surgery – Laparoscopic and robotic-assisted surgeries allow for smaller incisions, faster recovery times, and fewer complications.
• Targeted Therapies – These treatments attack specific genetic mutations in cancer cells, leading to more personalized and effective treatment plans.
• Immunotherapy – By boosting the body’s immune response, these therapies have shown promise in certain colorectal cancers, particularly those with mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) tumors.
Naples Cancer Advisors: Your Local Resource for Cancer Support
Naples Cancer Advisors is dedicated to serving the Southwest Florida community by providing:
• Free Consultative Second Opinions – Expert reviews of diagnoses and treatment plans to ensure patients receive the best care.
• Genetic Testing & Counseling – Helping individuals understand their hereditary cancer risks and take proactive steps.
• Financial Advocacy – Assisting patients in navigating the costs of treatment and finding available financial support.
Dr. Jazieh and the team at Naples Cancer Advisors are committed to ensuring every patient has access to the most advanced screening, treatment, and support available—at no cost.
Take Charge of Your Health
If you’re 45 or older, or have risk factors such as family history, inflammatory bowel disease, or certain genetic conditions, don’t wait—schedule your colorectal cancer screening today. Early detection saves lives!
For free second opinions, genetic testing, and financial support, contact Naples Cancer Advisors at (239) 846-2273 (CARE) or visit our website to learn more.
Dr. Jazieh’s bio:
Dr. Jazieh is deeply passionate about helping others. His passion for people’s health is the driving force that led him to become an oncologist to alleviate cancer patients’ suffering and enhance their chances of a cure. He aims to provide next-level oncology expertise to patients throughout their cancer journey and find the right balance between hope and science that fits each individual and ensures their best quality of life.
Dr. Jazieh joins the Naples Cancer Advisors team as a Senior Oncology Consultant and its Director of Innovation and Research, as well as the Director of International Programs.
He received his Doctor of Medicine from Damascus University in Syria and his Master of Public Health degree from Tulane University in New Orleans, Louisiana. Dr. Jazieh performed his Internal Medicine Residency at St. Francis Hospital in Evanston, Illinois, and Hematology and Medical Oncology at the University of Arkansas for Medical Sciences, Little Rock, Arkansas. He is board certified in Medical Oncology.
Dr. Jazieh’s compassionate heart for advancing evidence-based medicine within the oncology community is steeped in decades of service rendered to many professional cancer organizations. the Editor-in-Chief of the Global Journal on Quality and Safety in Healthcare since November 2017, and was the former Chairman of the International Affairs Committee of the American Society of Clinical Oncology, the largest society for oncology in the world and he is the Chairman-Elect for ASCO International Quality Committee. Dr. Jazieh established the Association of VA Hematology Oncology (avaho.org), a national organization of professionals who provide care to our veterans.
He published more than 150 articles, books, and book chapters. Dr. Jazieh has won multiple honors, including a Proclamation to the City of Cincinnati, naming a day in the City as Dr. Abdul Rahman Jazieh Day in 2006, and Special Recognition from NCCN as Global Partner in Cancer Care 2018. Merit Award Recipient from ASCO, “40 under 40” People to Watch at the UC Medical Center, “Unsung Hero Award” by Cancer Family Care, Cincinnati.
Bringing his world-renowned expertise and global perspective, Dr. Jazieh further enhances the world-class cancer care and cancer second opinions offered by the Naples Cancer Advisors Oncology team.
239-846-2273 (CARE)
3201 Tamiami Trail N, Suite 112, Naples, FL 34103
naplescanceradvisors.org
References
1. American Cancer Society. Colorectal Cancer: Early Detection, Diagnosis, and Staging. [www.cancer.org](https://www.cancer.org/cancer/types/
colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html)
2. National Cancer Institute. Colorectal Cancer Research Updates.
[www.cancer.gov](https://www.cancer.gov/types/colorectal/research)
3. CDC Florida Cancer Data. Colorectal Cancer Trends in Florida.
[ftp.cdc.gov](https://ftp.cdc.gov/pub/publications/cancer/ccc/
florida_ccc_plan-508.pdf)
4. U.S. Preventive Services Task Force. Screening Recommendations for
Colorectal Cancer. [www.uspreventiveservicestaskforce.org]
(https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/
colorectal-cancer-screening)